{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T15:09:34Z","timestamp":1724944174687},"reference-count":16,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2014,2,17]],"date-time":"2014-02-17T00:00:00Z","timestamp":1392595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Viral Hepatitis"],"published-print":{"date-parts":[[2014,7]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Treating chronic hepatitis C with pegylated interferon alpha may induce or exacerbate psychiatric illness including depression, mania and aggressive behaviour. There is limited data regarding treatment in the context of chronic schizophrenia. We sought to establish the safety and efficacy of treating patients with schizophrenia. Patient and treatment data, prospectively collected on the Scottish hepatitis C database, were analysed according to the presence or absence of a diagnosis of schizophrenia. Time from referral to treatment, and the proportion of patients commencing treatment in each group, was calculated. Outcomes including sustained viral response rates, reasons for treatment termination and adverse events were compared. Of 5497 patients, 64 (1.2%) had a diagnosis of schizophrenia. Patients with schizophrenia (<jats:styled-content style=\"fixed-case\">PWS<\/jats:styled-content>) were as likely to receive treatment as those without [28\/61(46%) vs 1639\/4415 (37%) <jats:italic>P<\/jats:italic>\u00a0=\u00a00.19]. Sustained viral response (<jats:styled-content style=\"fixed-case\">SVR<\/jats:styled-content>) rates were higher in <jats:styled-content style=\"fixed-case\">PWS<\/jats:styled-content> [21\/25 (84%) vs 788\/1453 (54%) <jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.01]. <jats:styled-content style=\"fixed-case\">SVR<\/jats:styled-content> rates by genotype were similar [4\/8 (50%) vs 239\/684 (35%) Genotype 1 (<jats:italic>P<\/jats:italic>\u00a0=\u00a00.56), 17\/17 (100%) vs 599\/742 (81%) non\u2010Genotype 1 (<jats:italic>P<\/jats:italic>\u00a0=\u00a00.09)]. Adverse events leading to cessation of treatment were comparable [2\/25(8%) vs 189\/1453 (13%) <jats:italic>P<\/jats:italic>: 0.66]. Patients with schizophrenia are good candidates for hepatitis C treatment, with equivalent <jats:styled-content style=\"fixed-case\">SVR<\/jats:styled-content> and treatment discontinuation rates to patients without schizophrenia.<\/jats:p>","DOI":"10.1111\/jvh.12234","type":"journal-article","created":{"date-parts":[[2014,2,18]],"date-time":"2014-02-18T02:16:51Z","timestamp":1392689811000},"source":"Crossref","is-referenced-by-count":5,"title":["The efficacy and safety of treating hepatitis C in patients with a diagnosis of schizophrenia"],"prefix":"10.1111","volume":"21","author":[{"given":"M. Z.","family":"Mustafa","sequence":"first","affiliation":[{"name":"Gastrointestinal Unit Glasgow Royal Infirmary Glasgow UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Schofield","sequence":"additional","affiliation":[{"name":"NHS Greater Glasgow and Clyde Glasgow UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. R.","family":"Mills","sequence":"additional","affiliation":[{"name":"Gartnavel General Hospital Glasgow UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Priest","sequence":"additional","affiliation":[{"name":"Gartnavel General Hospital Glasgow UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Fox","sequence":"additional","affiliation":[{"name":"Gartnavel General Hospital Glasgow UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Datta","sequence":"additional","affiliation":[{"name":"Victoria Infirmary Glasgow UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Morris","sequence":"additional","affiliation":[{"name":"Southern General Hospital Glasgow UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. H.","family":"Forrest","sequence":"additional","affiliation":[{"name":"Gastrointestinal Unit Glasgow Royal Infirmary Glasgow UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Gillespie","sequence":"additional","affiliation":[{"name":"Gastrointestinal Unit Glasgow Royal Infirmary Glasgow UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. J.","family":"Stanley","sequence":"additional","affiliation":[{"name":"Gastrointestinal Unit Glasgow Royal Infirmary Glasgow UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. T.","family":"Barclay","sequence":"additional","affiliation":[{"name":"Gastrointestinal Unit Glasgow Royal Infirmary Glasgow UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,2,17]]},"reference":[{"key":"e_1_2_8_2_1","first-page":"1","volume-title":"Hepatitis C in the UK 2011","author":"Health Protection Agency","year":"2011"},{"key":"e_1_2_8_3_1","volume-title":"Psychiatric morbidity among adults living in private households","author":"Singleton N","year":"2000"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.91.1.31"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psy.48.5.405"},{"key":"e_1_2_8_6_1","unstructured":"Summary of Product Characteristics (SPC) for Interferon \u03b1 2a and 2b. Available at:http:\/\/www.medicines.org.uk\/EMC\/medicine\/10081\/SPC\/Pegasys+135mcg+and+180mcg++solution+for+injection+in+Pre-filled+Syringe+Pre-filled+Pen\/andhttp:\/\/www.medicines.org.uk\/EMC\/medicine\/10321\/SPC\/ViraferonPeg+Pen+50%2c+80%2c+100%2c+120+or+150+micrograms++powder+and+solvent+for+solution+for+injection+in+pre-filled+pen\/(accessed 05 February 2014)."},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.099150"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.3851\/IMP1493"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21791"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbn065"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.57.3.403"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1086\/595685"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.35950"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbn106"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.55.8.892"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2008.02065.x"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1214854"}],"container-title":["Journal of Viral Hepatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvh.12234","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvh.12234","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvh.12234","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T07:28:08Z","timestamp":1695540488000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jvh.12234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,17]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["10.1111\/jvh.12234"],"URL":"https:\/\/doi.org\/10.1111\/jvh.12234","archive":["Portico"],"relation":{},"ISSN":["1352-0504","1365-2893"],"issn-type":[{"value":"1352-0504","type":"print"},{"value":"1365-2893","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,17]]}}}